NCT01739387View on ClinicalTrials.gov

A Study Assessing Patient Handling of Flutiform® Breath-Actuated Inhaler (BAI) and Flutiform® Pressurised Metered Dose Inhaler (pMDI)

CompletedOBSERVATIONAL

Enrollment

332

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions

AsthmaCOPD

Interventions

DEVICE

Flutiform® pMDI and Breath Actuated Inhaler (BAI)

Both devices contain placebo

Trial Locations (2)

Unknown

BioKinetic Europe Ltd, Belfast

Glasgow Clinical Research Facility, Glasgow

All Listed Sponsors

lead

Mundipharma Research Limited

INDUSTRY

NCT01739387 - A Study Assessing Patient Handling of Flutiform® Breath-Actuated Inhaler (BAI) and Flutiform® Pressurised Metered Dose Inhaler (pMDI) | Biotech Hunter | Biotech Hunter